Market Highlights:
Market Research Future (MRFR) has released a new research report on the global Apoptosis Assays Market Share The global apoptosis assays market held a market value of USD 2.99 billion in 2017 and is expected to register a CAGR of 9.4% during the forecast period.
Apoptosis is the natural, pre-programmed cell death occurring to accommodate the growth of the organism. Studying apoptosis processes has become a crucial avenue for healthcare researchers in the last few years due to its importance in cancer research and studies of cell behavior. Growing cell-based research to understand the intricacies of cell behavior is likely to be a major driver for the global apoptosis assays market over the forecast period. Cell-based research is likely to remain a promising and lucrative avenue for medical researchers in the coming years due to the application of cellular therapies in a number of diseases. The growing government support to cellular research in the form of funding is also likely to remain a major driver for the global apoptosis assays market over the forecast period.
Regional Analysis:
The global apoptosis assays market is segmented by region into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas, led by North America, is likely to be the major regional segment of the global apoptosis assays market over the forecast period. The healthy medical research sector in North America is likely to be a key driver for the global apoptosis assays market over the forecast period, as is the strong stem cell research and cancer research scenarios in the region. Europe is also likely to hold a dominant share in the global apoptosis assays market, following North America, due to the presence of a well-stocked, well-funded medical research sector.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6799
Key Players:
Some of the key players in the global Apoptosis Assays market are WuXi AppTec, Charles River, SGS SA, Merck KGaA, NORTH AMERICAN SCIENCE ASSOCIATES INC., Becton, Dickinson, and Company, Nelson Laboratories, LLC, Pacific Biolabs, ATS Laboratories, Inc., and Dynatec Labs.
Segmentation:
The global apoptosis assays market has been segmented into product, detection technology, application, and end user.
Based on product, the market is segmented into kits, reagents, instruments, and others. The kits segment accounted for the largest share and fastest growing segment of the global apoptosis assays market in 2017.
Based on detection technology, the market is segmented into flow cytometry, fluorescence microscopy, western blot assessment, gel electrophoresis, and others. The flow cytometry segment accounted for the largest share segment of the global apoptosis assays market in 2017.
Based on application, the market has been segmented into drug discovery and development, stem cell research, and others. The drug discovery and development segment accounted for the largest share of the global apoptosis assays market in 2017. The stem cell research was the fastest growing segment of the global apoptosis assays market in 2017.
Based on end user, the market has been segmented into pharmaceutical and biological companies, research institutes, and others. The pharmaceutical and biological companies segment accounted for the largest share of the global apoptosis assays market in 2017. Research institutes were the fastest growing segment of the global apoptosis assays market in 2017.
Key Players:
Some of the prominent players in the global apoptosis assays market are Abcom plc (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Sartorius AG (Germany), Geno Technology (US), GeneCopoeia, Inc. (US), and Promega Corporation (US).
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/apoptosis-assays-market-6799
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
Factors contributing to the growth of this market include the rising incidence and prevalence of chronic and infectious diseases, growing funding for cancer research, growing cell-based research, and development of apoptosis-modulating drugs.The global apoptosis assays market is projected to reach USD 5.9 billion by 2023 from USD 3.6 billion in 2018, at a CAGR of 10.5%.Based on detection technology, the cell imaging and microscopy is expected to grow at the fastest growth rate during the forecast period.
The cell imaging and microscopy segment is expected to witness the highest CAGR due to its increasing adoption of cell imaging and microscopy in diagnostic laboratories, drug discovery applications, and basic research.On the basis of product, the assay kits segment is expected to account for the largest share of the market in 2018.
The large share can be attributed to the repeated consumption of assays in various apoptosis procedures.
On the other hand, among all the detection technology, the flow cytometry is most widely used for apoptosis process.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=9069428Region Covered in Apoptosis Assay MarketThe apoptosis assays market in APAC is expected to grow at the highest CAGR during the forecast period.
The highest CAGR is due to the increasing prevalence of chronic and infectious diseases in this region, large patient population, increasing healthcare spending, and growing interest of key players in APAC countries.
Also, owing to the high growth opportunities in the APAC region, many manufacturers are expanding their global manufacturing bases to this region.With their low-cost manufacturing advantage, China and India are regarded as the most profitable manufacturing and R locations by manufacturers.
